科學+家 混合肌醇 | SCIENTIST HOME Mixed Inositol 150g

inositol
HK$540.00
In stock
1
Product Details
品牌 Brand: Scientist Home
多囊卵巢综合征(PCOS)


多囊卵巢綜合征(PCOS)影響5%-10%的育齡婦女,是卵巢功能不全和月經不調引起不孕的最常見原因。有幾項研究報導,無論體重指數如何,多囊卵巢綜合征婦女普遍存在胰島素抵抗。胰島素增敏化合物被認為是解决高胰島素血症引起的卵巢對內源性促性腺激素反應功能障礙的有效治療方法,這也提示了胰島素抵抗在多囊卵巢綜合征中的重要性。挽救卵巢對內源性促性腺激素的反應可降低高雄激素血症,並重建月經週期和排卵,新增自然懷孕的機會。在胰島素增敏化合物中,有肌醇。先前的研究已經證明,在大多數多囊卵巢綜合征患者中,MYO能够恢復自發的卵巢活動,從而恢復生育能力。現就MYO治療多囊卵巢綜合征(PCOS)的臨床療效、代謝及激素水准進行綜述。

症狀包含: 月經不規律或無月經、月經量過多、多毛症、粉刺、盆腔疼痛、難以受孕、黑棘皮症等等

科學+家 混合肌醇

可能適合多學科復康調理:

  • 周期不适(1,2,3)
  • 頭髮稀疏(4)
  • 唇毛(5)
  • 体毛(5)
  • 粉刺(6)
  • 睡眠障碍(7)

飲用方法: 每日二次,每次一至两平量匙, 餐后以250毫升温水冲开后饮用

注意事項:個別人士可能對肌醇有敏感反應,或出現非腹痛感的輕微腹瀉,均屬正常現象 (飲用後1小時內勿出街).

注意:

  1. 本品為營養補充劑,不用於替代藥物。
  2. 不適合飲用本補充劑包括:
    1. 懷孕
    2. 嬰幼兒
  3. 如果出現過敏或不良反應,請停止服用。
  4. 如不瞭解問題原因或問題持續,請儘快諮詢醫生。

主要成份: 肌醇、D-手性肌醇

規格型號:150克一瓶

份量:7至15天

儲存:請存放於陰涼乾爽處,避免陽光照射

產地:中國香港

如你有任何疾病, 請遵照閣下醫生的完整醫療方案; 而是否使用多學科復康方案前, 你必須咨詢主診醫生的意見, 如果閣下的主診醫生不建議您加入補充劑調理組合, 請你不要使用。如果你需要尋求其他醫生作第二咨詢, 閣下可聯絡我們線上<無邊界醫生>或你自己城市內的其他專業醫生的再診斷。

__


POLYCYSTIC OVARY SYNDROME (PCOS)
Polycystic Ovary Syndrome (PCOS) affects 5%-10% of women in reproductive age, and it is the most common cause of infertility due to ovarian dysfunction and menstrual irregularity. Several studies have reported that insulin resistance is common in PCOS women, regardless of the body mass index. The importance of insulin resistance in PCOS is also suggested by the fact that insulin-sensitizing compounds have been proposed as putative treatments to solve the hyperinsulinemia-induced dysfunction of ovarian response to endogenous gonadotropins. Rescuing the ovarian response to endogenous gonadotropins reduces hyperandrogenemia and re-establishes menstrual cyclicity and ovulation, increasing the chance of a spontaneous pregnancy. Among the insulin-sensitizing compounds, there is myo-inosiol (MYO). Previous studies have demonstrated that MYO is capable of restoring spontaneous ovarian activity, and consequently fertility, in most patients with PCOS. With the present review, we aim to provide an overview on the clinical outcomes of the MYO use as a treatment to improve ovarian function and metabolic and hormonal parameters in women with PCOS.
Symptoms: Irregular Menstruation, Menorrhagia, Hirsutism, Acne, Pelvic Pain, Difficult To Conceive, Acanthosis Nigricans
SCIENTIST HOME MIXED INOSITOL
Suggested multidisciplinary rehabilitation:
  • Periodic discomfort(1,2,3)
  • Thinning hair(4)

  • Labial hair(5)
  • Body hair(5)
  • Acne(6)
  • Sleep disturbances(7)

Consumption: 1 to 2 teaspoons each time after meal, to be taken once or twice a day. May dissolve the powder in water, juice or tea.

Note: If you're sensitive towards inositol, mild diarrhea without abdominal pain is normal. Suggest do not go out within 1 hour after taking.

Caution:

  1. This product is a nutritional supplement, and cannot replace medicine.
  2. Do not take this supplement if:
    • Pregnant or breastfeeding.
    • Infants and young children.
  3. To stop taking if allergic or adverse reactions occur (other than the normal healing reactions listed above).
  4. If you do not understand the cause of your health condition or the issue persists, please consult your doctor as soon as possible.

Main Ingredients: Inositol, D-Chiral Inositol

Specification: 150g per bottle

Serving size: 7 to 10 days

Storage: Please store in a cool and dry place

Origin: Hong Kong, China

If you have a medical condition, please follow your doctor's medical treatment plan. Do consult your medical doctor before using the Multidisciplinary Rehabilitation Program (MRP). Please do not proceed if your medical doctor does not recommend the use of our MRP. If you'd like to seek a second opinion from other doctors, you may contact our online "Doctors Without Border", or other professional doctors at your convenience.

__


參考研究 / Ref:

1. Gerli S, Papaleo E, Ferrari A, et al. Randomized, double-blind, placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. Eur Rev Med Pharmacol Sci. 2007;11:347-354

2. Costantino D, Minozzi G, Minozzi E, Guaraldi C. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary
syndrome: a double-blind trial. Eur Rev. Med Pharmacol Sci. 2009;13(2):105-110.

3. Raffone E, Rizzo P, Benedetto V. Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. Gynecol Endocrinol. 2010;26(4):275-280.

4. Ablon Glynis, MD, FAAD. A Double-blind, Placebo-controlled Study Evaluating the Efficacy of an Oral Supplement in Women with Self-perceived Thinning Hair. J Clin Aesthet Dermatol. v.5(11); 2012 Nov. PMC3509882

5. M Minozzi,1 G D’Andrea,2 V Unfer2,31First Institute of Obstetrics and Gynecology, University La Sapienza; 2A.G.UN.CO. Obstetrics and Gynecology Centre, Rome, Italy. Treatment of hirsutism with myo-inositol: a prospective clinical study. RBMOnline - Vol 17 No 4. 2008 579-582 Reproductive BioMedicine Online; www.rbmonline.com/Article/3299 on web 20 August 2008.

6. Michele Pezza, Valentina Carlomagno, Ambulatorio di Dermatologia Casa di Cura Villa Maria Passo di Mirabella Eclano (AV), Italy. Inositol in women suffering from acne and PCOS: a randomized study . DOI: 10.15761/GOD.1000203

7. Renae C Fernandez,1,2,3 Vivienne M. Moore,1,3,4 Emer M Van Ryswyk,5 Tamara J Varcoe,1,2 Raymond J Rodgers,1,2 Wendy. A March,1,3 Lisa J Moran,1,6 Jodie C Avery,1,2 R Doug McEvoy,5,7 and Michael J. Davies1,2. Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies. Journal
List Nat Sci Sleep v.10; 2018 PMC5799701

__

本品等並非根據《藥劑業及毒藥條例》或《中醫藥條例》注册。 任何對其提出的宣稱均不受此類登記評估的約束。 本產品不用於診斷、治療或預防任何疾病。

This product is not registered under the Pharmacy and Poisons Ordinance or the Chinese Medicine Ordinance. Any claim made for it has not been subject to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease.
Save this product for later